.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Expert Perspectives on the Treatment of Melanoma

EP. 1: Melanoma: BRAF Status and a Neoadjuvant Therapy Approach

July 18th 2019

EP. 2: Neoadjuvant Therapy in the Treatment of Melanoma

July 18th 2019

EP. 3: Adjuvant Therapy Options in Melanoma Treatment

July 18th 2019

EP. 4: Melanoma: Optimizing Selection of Adjuvant Therapy

July 18th 2019

EP. 5: Adjuvant Therapy for Locally Advanced Melanoma

July 18th 2019

EP. 6: Melanoma Progression Following Adjuvant Therapy

July 18th 2019

EP. 7: Immunotherapy vs TKIs in BRAF+ Metastatic Melanoma

July 18th 2019

EP. 8: Metastatic Melanoma: Key Trial Updates

July 18th 2019

EP. 9: Managing Melanoma Brain Metastases

July 18th 2019

EP. 10: Management of Relapsed/Refractory Metastatic Melanoma

July 18th 2019